Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Liver Diseases and Immunity

TopicLeading institutions, researchers & key papers

This cluster of papers focuses on the diagnosis, management, epidemiology, and genetic factors of autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis. It also covers topics such as liver transplantation, immunosuppressive therapy, and the pathogenesis of these liver diseases.

369
Works

How has Liver Diseases and Immunity's publication output changed over time?

ScholarIQpublication output · 2004–2019

Output grew100% over the shown period — from 1 works in 2004 to 2 in 2019.

1
1
1
1
2
1
1
2
2
2
2004200520082010201320142015201620172019

What are the most-cited papers on Liver Diseases and Immunity?

ScholarIQmost cited works
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
Frederik Nevens, Pietro Andreoné, G. Mazzella, Simone I. Strasser, Christopher L. Bowlus, Pietro Invernizzi, Joost P.H. Drenth, Paul J. Pockros, Jarosław Reguła, Ulrich Beuers, Michael Trauner, David Jones, Annarosa Floreani, Simon Hohenester, Velimir A. Luketic, Mitchell L. Shiffman, Karel J. van Erpecum, Vı́ctor Vargas, Catherine Vincent, Gideon M. Hirschfield, Hemant Shah, Bettina E. Hansen, Keith D. Lindor, Hanns–Ulrich Marschall, Kris V. Kowdley, Roya Hooshmand-Rad, Tonya Marmon, Shawn Sheeron, Richard Pencek, Leigh MacConell, Mark Pruzanski, Д. А. Шапиро
New England Journal of Medicine. 20161,120 CitationsOPEN ACCESS
Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases
Cara L. Mack, David Adams, David N. Assis, Nanda Kerkar, Michael P. Manns, Marlyn J. Mayo, Simon C. Ling, Mouaz Alsawas, M. Hassan Murad, Albert J. Czaja
S156174673. 2019941 CitationsOPEN ACCESS
Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis
Kirsten Boonstra, Rinse K. Weersma, Karel J. van Erpecum, Erik A. Rauws, B.W.M. Spanier, Alexander C. Poen, Karin M. van Nieuwkerk, Joost P.H. Drenth, Ben Witteman, Hans A.R.E. Tuynman, A.H.J. Naber, Paul J. Kingma, Henk R. van Buuren, Bart van Hoek, Frank P. Vleggaar, Nan van Geloven, Ulrich Beuers, Cyriel Y. Ponsioen, on behalf of the EpiPSCPBC Study Group
S156174673. 2013726 CitationsOPEN ACCESS
Primary sclerosing cholangitis
Gideon M. Hirschfield, Tom H. Karlsen, Keith D. Lindor, David Adams
The Lancet. 2013593 Citations
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
Tobias J. Weismüller, Palak Trivedi, Annika Bergquist, Mohamad Imam, Henrike Lenzen, Cyriel Y. Ponsioen, Kristian Holm, Daniel Gotthardt, Martti Färkkilâ, Hanns–Ulrich Marschall, Douglas Thorburn, Rinse K. Weersma, Johan Fevery, Tobias Mueller, Olivier Chazouillères, Kornelius Schulze, Konstantinos N. Lazaridis, Sven Almér, Stephen P. Pereira, Cynthia Levy, Andrew L. Mason, Sigrid Næss, Christopher L. Bowlus, Annarosa Floreani, Emina Halilbasic, Kidist Yimam, Piotr Milkiewicz, Ulrich Beuers, Dep Huynh, Albert Parés, Christine N. Manser, George Ν. Dalekos, Bertus Eksteen, Pietro Invernizzi, Christoph P. Berg, Gabi I. Kirchner, Christoph Sarrazin, Vincent Zimmer, Luca Fabris, Felix Braun, Marco Marzioni, Brian D. Juran, Karouk Said, Christian Rupp, Kalle Jokelainen, M Valle, Francesca Saffioti, Angela Cheung, Michael Trauner, Christoph Schramm, Roger W. Chapman, Tom H. Karlsen, Erik Schrumpf, Christian P. Strassburg, Michael P. Manns, Keith D. Lindor, Gideon M. Hirschfield, Bettina E. Hansen, Kirsten Muri Boberg
Gastroenterology. 2017526 CitationsOPEN ACCESS

Where is Liver Diseases and Immunity research published, and who funds it?

ScholarIQvenues & funding sources

TOP JOURNALS

TOP FUNDERS

National Science Foundation
NIH
Wellcome Trust
European Research Council
Funder breakdown is a member featureSign up free to unlock

How much of the research on Liver Diseases and Immunity is open access?

ScholarIQopen access share
60%OPEN ACCESS
Gold
7%
Green
0%
Hybrid
7%
Bronze
47%
Closed
40%

Related on ScholarIQ

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Paper
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
Paper
Model for end-stage liver disease (MELD) and allocation of donor livers
Paper
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
Paper
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Paper
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
Paper
470M+ articles · free account